介入性影像市場－全球產業規模、佔有率、趨勢、機會、預測：按交付方式、應用、地區和競爭格局分類，2021-2031年

全球介入影像市場預計將從 2025 年的 260.1 億美元成長到 2031 年的 357.4 億美元，複合年成長率為 5.44%。

該市場涵蓋透視、CT 和超音波等醫療技術，這些技術可提供即時成像，從而指導微創手術。該市場的成長主要受以下因素驅動：心血管疾病和癌症等慢性疾病的日益普遍，這些疾病需要精準的術中引導；以及醫學界向微創介入治療的廣泛轉變，與傳統手術相比，微創介入治療可縮短住院時間，加快患者康復。

然而，市場擴張面臨的主要障礙是操作這些複雜系統和解讀數據所需的熟練介入放射科醫生和技術人員嚴重短缺。根據美國放射學會 (ACR) 預測，到 2025 年，約 67% 的放射科醫師將面臨人手不足的問題。這種嚴重的短缺限制了醫療機構應對日益成長的檢查數量的能力，並阻礙了已開發市場和新興市場對先進介入解決方案的採用。

市場促進因素

全球介入影像市場最大的驅動力是慢性病和心血管疾病盛行率的不斷上升。隨著複雜疾病在全球範圍內負擔加重，醫療機構越來越依賴影像引導療法，以提供精準、微創的治療，從而改善患者預後。流行病學預測也印證了這一日益成長的需求，例如美國癌症研究協會預測，到2025年，美國將新增2,041,910例癌症病例，這促使醫院擴大介入治療能力，並加快採用先進的透視和CT系統。

推動市場發展的第二個關鍵因素是技術創新，特別是人工智慧 (AI) 和機器人輔助介入技術的融合。製造商正在迅速採用 AI 演算法來自動化複雜的工作流程，減少輻射暴露，並提高精細手術中即時影像的清晰度。這一趨勢得到了重要的監管里程碑的支持，例如 GE 醫療計劃在 2025 年 7 月前獲得 100 項 FDA核准的 AI醫療設備。這項技術進步正在轉化為巨大的經濟效益，例如波士頓科學公司公佈的 2024 會計年度淨銷售額為 167 億美元，凸顯了介入醫學的巨大盈利潛力。

市場挑戰

熟練的介入放射科醫師和技術人員嚴重短缺是全球介入影像市場的主要阻礙因素。這些先進的系統需要高度專業化的人員來執行複雜的術中操作並準確解讀即時數據。當醫療機構面臨合格人員短缺時，這些資本密集設備的效用將顯著降低。這種短缺迫使醫院限制微創手術的數量，導致臨床容量受限，抑制了醫療機構採用更多影像系統的意願，最終導致市場需求放緩。

人員短缺對新型介入技術的普及率產生了實質的影響。如果沒有足夠的訓練有素的專業人員，就難以證明昇級和擴大影像科室的投資回報是合理的。例如，英國皇家放射學院報告稱，到2024年，英國臨床放射科醫生的缺口英國達到29%。如此嚴重的短缺限制了醫療中心處理患者的能力，從而阻礙了用於投資市場上最新影像技術的收入成長。

市場趨勢

市場的一個根本結構轉變是將介入手術轉移到“門診手術中心（ASC）”，這與傳統的醫院擴建模式截然不同。保險公司和醫療服務提供者正積極將周邊血管疾病、疼痛管理和基礎介入放射學病例轉移到這些門診機構，以提高營運效率並顯著降低管理成本。對於大規模醫療系統而言，這種轉變是財務上的必然選擇，它們正在收購獨立中心，以確保高利潤的門診收入來源，同時保留大型醫院設施用於重症監護。這種加速發展的勢頭在領先營運商強勁的財務業績中得到了清晰體現，例如，泰尼特醫療集團（Tenet Healthcare）的門診護理部門預計到2025年10月淨營業收入將達到12.75億美元，成長11.9%，顯著優於傳統醫院的運營水平。

同時，領先的醫療中心正優先採用混合手術室，以應對日益複雜的手術。這些先進的手術室將傳統手術室的無菌環境與高性能固定式影像系統相結合，使多學科團隊能夠在不移動患者的情況下進行複雜的血管和心臟修復手術，這與標準導管檢查室截然不同。這種功能整合對於治療重症患者至關重要，因為它允許在手術過程中出現併發症時立即從微創手術切換到開放性手術。對這些資本密集環境的持續投資不斷推動著專用介入硬體的銷售，西門子醫療的「先進療法」部門預計到2025年11月銷售額將成長3.8%。這主要歸功於對這些混合手術環境所需的高階血管造影術和手術支援系統的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球介入影像市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（CT掃描儀、X光系統、MRI系統、超音波影像影像系統、其他）
  • 依應用領域（循環系統、神經、肌肉骨骼、腫瘤、泌尿系統、消化、產科、婦科等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美介入影像市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲介入影像市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區介入影像市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲介入影像市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲介入影像市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球介入影像市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Interventional Imaging Market is projected to grow from USD 26.01 Billion in 2025 to USD 35.74 Billion by 2031, at a 5.44% CAGR. This market encompasses medical technologies like X-ray fluoroscopy, CT, and ultrasound, which provide real-time visualization for guiding minimally invasive surgical procedures. The market's growth is primarily fueled by the rising prevalence of chronic conditions such as cardiovascular diseases and cancer, requiring precise intraoperative guidance, and a broader healthcare shift towards minimally invasive interventions that offer shorter hospital stays and quicker patient recovery compared to traditional surgeries.

A significant hurdle to market expansion, however, is the critical shortage of skilled interventional radiologists and technicians essential for operating these complex systems and interpreting data. In 2025, approximately 67% of radiologists reported understaffing in their practices, according to the American College of Radiology. This substantial workforce gap limits healthcare facilities' capacity to handle increasing procedural volumes and constrains the wider adoption of advanced interventional solutions across both developed and emerging markets.

Market Driver

The foremost driver propelling the Global Interventional Imaging Market is the increasing prevalence of chronic and cardiovascular diseases. As the global burden of complex conditions grows, healthcare providers are increasingly relying on image-guided therapies to deliver precise, minimally invasive treatments that enhance patient outcomes. This escalating demand is supported by epidemiological projections, such as the American Cancer Society's forecast of 2,041,910 new cancer cases in the United States in 2025, prompting hospitals to expand interventional capabilities and boost procurement of advanced fluoroscopy and CT systems.

The second critical force stimulating market development is technological innovation, specifically the integration of artificial intelligence and robotic-assisted interventions. Manufacturers are rapidly deploying AI algorithms to automate complex workflows, reduce radiation exposure, and improve real-time image clarity during delicate surgeries. This trend is demonstrated by significant regulatory milestones, including GE HealthCare securing 100 FDA authorizations for AI-enabled medical devices by July 2025. This technological evolution translates into substantial economic activity, with companies like Boston Scientific reporting $16.7 billion in full-year 2024 net sales, highlighting the lucrative nature of interventional medicine.

Market Challenge

The critical shortage of skilled interventional radiologists and technicians acts as a primary restraint on the global interventional imaging market. These advanced systems demand highly specialized personnel to navigate complex intraoperative procedures and accurately interpret real-time data. When healthcare facilities face a deficit of qualified operators, the utility of such capital-intensive equipment is severely compromised. This labor gap compels hospitals to restrict the volume of minimally invasive procedures they can offer, effectively capping operational capacity and discouraging providers from procuring additional imaging systems, thereby dampening market demand.

This workforce scarcity has tangible repercussions on the adoption rates of new interventional technologies. Without a sufficient pipeline of trained professionals, justifying the return on investment for upgrading or expanding imaging departments becomes challenging. For instance, the Royal College of Radiologists reported a 29% workforce shortfall for clinical radiologists in the United Kingdom in 2024. Such significant staffing voids limit medical centers' ability to manage patient throughput, thereby stalling the revenue growth necessary for reinvestment in the market's latest imaging innovations.

Market Trends

A fundamental structural shift in the market is the migration of interventional procedures to Ambulatory Surgical Centers (ASCs), distinct from traditional hospital-based capacity expansion. Payers and healthcare providers are aggressively redirecting peripheral vascular, pain management, and basic interventional radiology cases to these outpatient settings to leverage operational efficiencies and significantly reduced overhead costs. This transition is a financial imperative for large health systems, which are acquiring independent centers to capture high-margin outpatient revenue streams while reserving main hospital facilities for critical care. This accelerating momentum is evident in the strong financial performance of major operators, with Tenet Healthcare's Ambulatory Care segment seeing net operating revenues jump 11.9% to $1.275 billion by October 2025, substantially outperforming traditional hospital operations.

Simultaneously, leading medical centers are prioritizing the adoption of Hybrid Operating Room configurations to manage increasing procedural complexity. These advanced suites merge the sterility of a traditional surgical theater with high-end fixed imaging systems, enabling multidisciplinary teams to perform intricate vascular and structural heart repairs without requiring patient transport, unlike standard catheterization labs. This consolidation of capabilities is essential for treating higher-acuity patients, as it allows for immediate conversion from minimally invasive techniques to open surgery if intraoperative complications arise. Sustained investment in these capital-intensive environments continues to drive sales of specialized interventional hardware, with Siemens Healthineers' Advanced Therapies segment recording comparable revenue growth of 3.8% by November 2025, largely due to demand for sophisticated angiography and surgery-supporting systems for these hybrid settings.

Key Market Players

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation

Report Scope

In this report, the Global Interventional Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Interventional Imaging Market, By Offering

• CT Scanners
• X-Ray Systems
• MRI Systems
• Ultrasound Imaging Systems
• Others

Interventional Imaging Market, By Application

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynecology
• Others

Interventional Imaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Interventional Imaging Market.

Available Customizations:

Global Interventional Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Interventional Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Offering (CT Scanners, X-Ray Systems, MRI Systems, Ultrasound Imaging Systems, Others)
  • 5.2.2. By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Interventional Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Offering
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Interventional Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Offering
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Interventional Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Offering
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Interventional Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Offering
      • 6.3.3.2.2. By Application

7. Europe Interventional Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Offering
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Interventional Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Offering
      • 7.3.1.2.2. By Application
  • 7.3.2. France Interventional Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Offering
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Interventional Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Offering
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Interventional Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Offering
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Interventional Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Offering
      • 7.3.5.2.2. By Application

8. Asia Pacific Interventional Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Offering
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Interventional Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Offering
      • 8.3.1.2.2. By Application
  • 8.3.2. India Interventional Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Offering
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Interventional Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Offering
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Interventional Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Offering
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Interventional Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Offering
      • 8.3.5.2.2. By Application

9. Middle East & Africa Interventional Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Offering
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Interventional Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Offering
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Interventional Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Offering
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Interventional Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Offering
      • 9.3.3.2.2. By Application

10. South America Interventional Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Offering
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Interventional Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Offering
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Interventional Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Offering
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Interventional Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Offering
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Interventional Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Canon Inc.
• 15.3. Esaote SpA
• 15.4. FUJIFILM Holdings Corporation
• 15.5. Hologic, Inc.
• 15.6. Intuitive Surgical, Inc.
• 15.7. Koninklijke Philips NV
• 15.8. Medtronic plc
• 15.9. Siemens Healthineers AG
• 15.10. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer